Wird geladen...

Sustained complete response of hepatocellular carcinoma with portal vein tumor thrombus following discontinuation of sorafenib: A case report

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-associated mortality worldwide. No effective treatment has been established for unresectable advanced HCC, and the prognosis is poor. Sorafenib is an oral multi-targeted tyrosine kinase inhibitor for unresectable advanced HCC th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHIOZAWA, KAZUE, WATANABE, MANABU, IKEHARA, TAKASHI, MATSUKIYO, YASUSHI, KOGAME, MICHIO, KANAYAMA, MASAHIRO, MATSUI, TEPPEI, KIKUCHI, YOSHINORI, ISHII, KOJI, IGARASHI, YOSHINORI, SUMINO, YASUKIYO
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2014
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3861562/
https://ncbi.nlm.nih.gov/pubmed/24348819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2013.1664
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!